Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report.

Autor: de Joode K; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Veenbergen S; Laboratory of Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Kransse C; Laboratory of Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Kortleve D; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Debets R; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Joosse A; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Schreurs MWJ; Laboratory of Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands a.vanderveldt@erasmusmc.nl.; Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Feb; Vol. 11 (2).

Human CD79b⁺ neutrophils in the blood are associated with early-stage melanoma.

Autor: Meyer, Melissa A., Dinh, Huy Q., Alimadadi, Ahmad, Araujo, Daniel J., Chatterjee, Nandini, Gutierrez, Norma A., Zhu, Yanfang Peipei, Hunter, Emma L., Shu Liang, Seumois, Gregory, Kiosses, William B., Catz, Sergio D., Vijayanand, Pandurangan, Ottensmeier, Christian, Hedrick, Catherine C.

Publikováno v: Frontiers in Immunology; 2023, p1-14, 14p